Figure 1.
Depiction of the biosynthesis of UDP-GlcNAc and the effects conveyed on its substrates. UDP-GlcNAc is formed through the hexosamine biosynthetic pathway (HBP), combining several metabolites. O-GlcNAc cycling can modulate activity (CaMKII), stability (p53), and localization (NeuroD1) of its substrates.